Promoting Treatment Strategies that Enhance Family and Social Connectedness
Suicide is the second leading cause of death among youths ages 10-24 and suicide death rates are rising. This presentation describes the Family Intervention for Suicide Prevention, a component of the SAFETY program. This trauma-informed youth and family-centered approach aims to enhance protective processes and social connections in the family and social environment that can reduce the risk of suicidal behavior and improve the lives of youths who are struggling with suicidal and/or self-harm tendencies.
Resources:
Act, Support And Protect (ASAP) Website: https://www.asapnctsn.org/
Event Presenter(s)
Joan Asarnow, Ph.D. is a Professor of Psychiatry and Biobehavioral Sciences at UCLA and Director of the UCLA Youth Stress and Mood Program, a depression and suicide prevention program with clinical, educational, and research components. Dr. Asarnow has led efforts to develop and evaluate integrated medical-behavioral health care strategies for youths, with an emphasis on evidence-based treatments for youth depression and suicide and self-harm prevention. She received the 2017 Research Award from the American Foundation for Suicide Prevention for her work developing and evaluating treatment and service delivery strategies for youths suffering with suicidal and self-harm behaviors and currently leads two major federally funded programs: 1) a large NIMH-funded randomized controlled trial, with Kaiser Permanente Research Foundation, evaluating a stepped care intervention for adolescents and young adults aimed at advancing the goal of zero suicide within a large health system; and 2) the UCLA-Duke Center for Trauma-Informed Adolescent Suicide, Self-Harm & Substance Abuse Prevention. Two programs developed by Dr. Asarnow are listed in the National Registry for Evidence-Based Programs (SAMHSA): 1) the Family Intervention for Suicide Prevention, a crisis treatment for youths after a suicidal/self-harm episode; and 2) Depression Treatment Quality Improvement, an evidence-based depression treatment program that has been integrated within primary care, mental health, and other settings. Dr. Asarnow has received grants from the National Institute of Mental Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Substance Abuse and Mental Health Services Administration, American Foundation for Suicide Prevention, and other organizations. She currently serves on the Scientific Council of the American Foundation for Suicide Prevention and the Scientific Advisory Board of the Klingenstein Third Generation Foundation.
David Goldston, Ph.D. is a clinical psychologist and Associate Professor at Duke University School of Medicine in the Department of Psychiatry and Behavioral Sciences. He also is Co-Director of the UCLA-Duke (ASAP) Center for Trauma-Informed Suicide, Self-Harm, and Substance Use Prevention and Treatment, which is part of the National Child Traumatic Stress Disorder. He has conducted longitudinal and treatment research with suicidal youth and adults, is part of the team evaluating the Garrett Lee Smith Suicide Prevention Program, and he has a particular research interest in individuals with suicidal behavior with co-occurring substance use problems. He also serves as Administrative Director for the Duke Center for Adolescent and Young Adult Substance Treatment.
Jeanne Miranda, Ph.D. is a leading expert in developing and evaluating the impact of mental health care interventions on low-income and ethnic minority communities. For the past 30 years, she has led community-partnered research programs on depression treatments for under-resourced communities in the United States and abroad. She developed and is evaluating a resilience intervention for low-income and sexual and gender minority populations in Los Angeles and New Orleans. She has adapted and evaluated her depression interventions for youth in Uganda. Dr. Miranda was the Senior Scientific Editor of Mental Health: Culture, Race and Ethnicity: A Report of the Surgeon General. In 2005, she was elected to the Institute of Medicine, now the National Academy of Medicine. Dr. Miranda is the 2008 recipient of the Emily Mumford Award for Contributions to Social Medicine from Columbia University. She obtained her Ph.D. in Clinical Psychology from University of Kansas and completed her post-doctoral training at University of California, San Francisco (UCSF). From 1988-1992, she was a faculty member in the Department of Psychiatry at UCSF. In 1992, she moved to Washington, D.C. where she became an Associate Professor of Psychiatry at Georgetown University. In 2001, Dr. Miranda joined the David Geffen School of Medicine and became Professor in Residence in the Department of Psychiatry and Biobehavioral Sciences at UCLA.